propranolol has been researched along with calcitriol in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (20.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Lamberg-Allardt, C; Törnquist, K | 2 |
Baudet, C; Brachet, P; Canova, C; Chevalier, G; Wion, D | 1 |
Samina Riaz , S; Tomlinson, DR | 1 |
Gerhardt, A; Hackenberg, K | 1 |
Chen, H; Fajol, A; Föller, M; Lang, F; Quarles, LD; Umbach, AT | 1 |
1 review(s) available for propranolol and calcitriol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for propranolol and calcitriol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effect of 1,25-dihydroxy-cholecalciferol on the TRH induced TSH release in rats.
Topics: Animals; Calcitriol; Calcium; Edetic Acid; Female; Pituitary Gland; Propranolol; Rats; Rats, Inbred Strains; Thyrotropin; Thyrotropin-Releasing Hormone; Verapamil | 1987 |
Effect of 1,25(OH)2D3 on the TSH secretion from rat pituitary cells.
Topics: Animals; Calcitriol; In Vitro Techniques; Pituitary Gland, Anterior; Propranolol; Rats; Rats, Inbred Strains; Thyrotropin; Verapamil | 1986 |
Noradrenaline inhibits the programmed cell death induced by 1,25-dihydroxyvitamin D3 in glioma.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Apoptosis; Brain Neoplasms; Calcitriol; DNA Fragmentation; Glioma; Isoproterenol; Neurotransmitter Agents; Norepinephrine; Propranolol; Rats; Tumor Cells, Cultured | 1997 |
Pharmacological modulation of nerve growth factor synthesis: a mechanistic comparison of vitamin D receptor and beta(2)-adrenoceptor agonists.
Topics: 3T3 Cells; 8-Bromo Cyclic Adenosine Monophosphate; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Antineoplastic Agents; Calcitriol; Carcinogens; Clenbuterol; Colforsin; Gene Expression; Mice; Nerve Growth Factor; NF-kappa B; Propranolol; Receptors, Calcitriol; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcription, Genetic | 2000 |
Pseudohypoparathyroidism and Graves'disease: a rare combination of two endocrinological diseases.
Topics: Adult; Calcitriol; Calcium; Calcium Carbonate; Female; Graves Disease; Humans; Methimazole; Parathyroid Hormone; Phosphates; Propranolol; Pseudohypoparathyroidism; Thyrotropin; Thyroxine | 2002 |
Enhanced FGF23 production in mice expressing PI3K-insensitive GSK3 is normalized by β-blocker treatment.
Topics: Adrenergic beta-Antagonists; Animals; Calcitriol; Calcium; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glycogen Synthase Kinase 3; Kidney; Mice; Mice, Mutant Strains; Phosphates; Phosphatidylinositol 3-Kinases; Propranolol; Vanilmandelic Acid | 2016 |